Improving Tenoxicam Solubility and Bioavailability by Cosolvent System
- 545 Downloads
The formulation study of tenoxicam, a poorly water-soluble drug, was developed by use of a ternary cosolvent system and has significantly enhanced the solubility. Additionally, the relative bioavailability of testing formulation was also evaluated by New Zealand rabbit with a single i.m. injection. The three-phase diagram for dimethylsulfoxide (DMSO)/propylene glycol/water, DMSO/ethanol/water, and DMSO/polyethoxylated castor oil/ethanol system was developed. The volume ratio of 5:4:1 in the DMSO/polyethoxylated castor oil/ethanol system resulted in a more suitable vehicle than other systems, with a high solubility (20.73 mg/ml) and low viscosity (10.0 Cp). A pharmacokinetic study of bioequivalence (F rel = 0.89) was also obtained. The present study not only provides a novel strategy improving tenoxicam solubility but also helps further scientific knowledge for the development of parenteral formulations.
Key wordsbioavailability cosolvent system pharmacokinetics poorly water-soluble drug solubility tenoxicam
- 2.A. Yoshida, M. Yamamoto, T. Irie, F. Hirayama, and K. Uekama. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities. Chem. Pharm. Bull. (Tokyo). 37:1059–1063 (1989).Google Scholar
- 4.J. S. Trivedi, and M. L. Wells. Solubilization using cosolvent approach. Liu IR, (eds.), Water-Insoluble Drug Formulation, Interpharm, Denver, Colorado, 2000, pp. 141–168.Google Scholar
- 19.U. S. Schuler, M. Ehrsam, A. Schneider, H. Schmidt, J. Deeg, and G. Ehninger. Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation. Bone Marrow Transplant. 22:241–244 (1998).PubMedCrossRefGoogle Scholar